Twitter | Search | |
Alberto J. Lorenzatti, MD, MTFAC, FACC
Chief of Clinical Cardiology, Cordoba Hospital. Co-Director DAMIC Medical Institute / Rusculleda Foundation for Research. Cardiology, Lipids & CV Prevention.
27
Tweets
99
Following
115
Followers
Tweets
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC Nov 1
Cursos de RCP realizados por el Dr. Sergio Vissani de la Sociedad de Cardiología y Fundación Cardio de San Luis en el Colegio San Agustín y Club Huracán.
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC Nov 1
Si es miembro de FAC puede asociarse a la en forma gratuita y y obtener todos los beneficios. Ahora pueden hacerlo de manera directa: Por dudas escriba a mesadir@fac.org.ar
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC Oct 31
Te lo vas a perder?
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC Oct 30
'Sheriff' Cardiologist Sounds the Alarm on Ineffective Generics vía
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC Aug 8
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC Aug 8
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Nina Teicholz Jan 22
Ancel Keys, from U. MInn the most influential nutrition scientist of the last 100 years. His ideas formed the basis of our Dietary Guidelines as well as the Mediterranean diet. But was he right? Student reporter examines troubled legacy:
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Nina Teicholz Jan 24
In UK, leadership is demanding that results from ALL clinical trials be reported. Too often, results that are not 'convenient' are simply binned/ignored, never published (as w/ so many of the studies on Keys' hypothesis). We need full reporting in US, too
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Thomas Dayspring Jan 24
EAS Update - Cholesterol and inflammatory risk: Insights from secondary and primary prevention
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Dave Dixon Jan 17
No doubting the LDL-C lowering ability of evolocumab. Extremely consistent reductions with little interindividual variation.
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Thomas Dayspring 25 Jul 18
Lipidaholics Anonymous: CLICK TO ENLARGE - There seems to be lots of confusion with Lp(a) metrics - I hope this helps all better understand reported concentrations
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Cardio Debate 31 Jul 18
RT "This randomized clinical trial compares the effect of escitalopram vs placebo on long-term major adverse cardiovascular events among patients in Korea with depression following acute coronary syndrome: "
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
adrian baranchuk 4 Aug 18
Quieren saber QUE hay en el vino? Nuestro reciente articulo en Trends in Cardiovascular Medicine lo explica de manera sencilla.
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC 27 Jul 18
Dr. Adrián D´Ovidio, se trata del Lanzamiento Oficial de la Campaña de Prev. de Factores de Riesgo Card. en la niñez y los invita a sumarse porque "Hábitos saludables en la niñez, corazones sanos en el futuro"
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Ricardo Lopez Santi 25 Jul 18
Tu corazón late miles de veces cada hora y su cuidado depende de comer sano, descansar bien, act. física y del aire puro que respiras. Por eso a partir del 29/9 vamos en todo el mundo por l campaña “Mi corazón Tu corazón”
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC 25 Jul 18
Comenzamos con esta campaña de prevención de ECV en la niñez. Tenemos la participación de 23 niños de todo el país. Además de prestigiosos médicos que nos brindan información. Participá:
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
PCSK9 Forum 16 Jul 18
PCSK9 Forum posts new study showing that circulating does not influence beta-cell function
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Eric Topol 11 Jul 18
The barriers to changing medicine, exemplified by self-monitoring and remote management of blood pressure by +1 w/
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
Eric Topol 9 Jul 18
NAFLD—non-alcoholic fatty liver disease (and NASH)— is an epidemic projected to affect ~100 million Americans by 2030, expertly reviewed : and then there's the gut metabolite angle
Reply Retweet Like
Alberto J. Lorenzatti, MD, MTFAC, FACC retweeted
FAC 3 Jul 18
Cumplimos 53 años. Orgullosos de nuestra historia, y con políticas de continuidad que hacen que FAC lata cada vez más fuerte. En el video, el pte. Dr. D´, el vice 1o. y el vice 2o. Video completo:
Reply Retweet Like